MetaCap

MeiraGTx (MGTX) vs SL Science (SLBT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

MeiraGTx (MGTX) has outperformed SL Science (SLBT) over the past year, gaining 27.4% versus a loss of 85.4%. MeiraGTx is the larger company by market cap ($1.04 billion vs $846.7 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MGTX+27.44%SLBT-85.42%
+84%-5%-94%
Oct 7, 20251 yearOct 7, 2026
MGTX+58.88%SLBT-84.93%
+120%+13%-95%
Feb 3, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MGTX versus SLBT key metrics
MetricMGTXSLBT
Share price$10.82$1.51
Market cap$1.04B$846.75M
1-day change+2.08%-0.66%
YTD return+36.10%-85.68%
1-year return+27.44%-85.42%
5-year return-24.23%—
P/E ratio (TTM)12.44—
EPS (TTM)$0.87$-0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$15.35$14.50
52-week low$6.62$1.42
Distance from 52-week high-29.51%-89.59%
Average volume773.36K81.13K
Shares outstanding96.04M560.76M
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MGTX has outperformed SLBT by 112.9 percentage points over the past year.

MGTX vs SLBT FAQ

Which is bigger, MeiraGTx or SL Science?

MeiraGTx (MGTX) is larger, with a market capitalization of $1.04B compared with $846.75M for SL Science (SLBT).

Which stock has performed better over the past year, MGTX or SLBT?

MGTX returned +27.44% over the past 12 months, compared with -85.42% for SLBT (price return, excluding dividends). Past performance does not predict future results.

Are MeiraGTx and SL Science in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons